|
Volumn 32 Suppl 2, Issue , 2009, Pages
|
Defining and characterizing the progression of type 2 diabetes.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
ARTICLE;
BLOOD;
DISEASE COURSE;
GLUCOSE BLOOD LEVEL;
GLUCOSE TOLERANCE TEST;
HUMAN;
HYPERGLYCEMIA;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RESISTANCE;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PANCREAS ISLET BETA CELL;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
POSTPRANDIAL STATE;
SECRETION;
WEIGHT GAIN;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
GLUCOSE TOLERANCE TEST;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
INSULIN-SECRETING CELLS;
OBESITY;
POSTPRANDIAL PERIOD;
PREDIABETIC STATE;
WEIGHT GAIN;
MLCS;
MLOWN;
|
EID: 75549090118
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-s301 Document Type: Article |
Times cited : (434)
|
References (0)
|